医学知识

订阅

MedSci主页 / 所有栏目 / 医学知识

CONSORT规范简介

2018-04-11 MedSci MedSci原创

科研基金
关注

CONSORT规范简介

CONSORT规范简介





版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2188589, encodeId=1912218858956, content=consort指南 求PDF, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231107/fc1e00c3671a452b933329d067a6c170/0c2cee4450c449e48382ba22e7e48ddb.jpg, createdBy=19109053436, createdName=阳～晨, createdTime=Wed Feb 21 23:18:07 CST 2024, time=2024-02-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2021210, encodeId=87ce2021210e3, content=<a href='/topic/show?id=89df506ea9' target=_blank style='color:#2F92EE;'>#CONSORT规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5067, encryptionId=89df506ea9, topicName=CONSORT规范)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Thu Dec 13 06:54:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558468, encodeId=9b431558468da, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564477, encodeId=3c4e15644e782, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304803, encodeId=8b603048038d, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:40 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2024-02-21 阳～晨 来自辽宁省

    consort指南 求PDF

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2188589, encodeId=1912218858956, content=consort指南 求PDF, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231107/fc1e00c3671a452b933329d067a6c170/0c2cee4450c449e48382ba22e7e48ddb.jpg, createdBy=19109053436, createdName=阳～晨, createdTime=Wed Feb 21 23:18:07 CST 2024, time=2024-02-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2021210, encodeId=87ce2021210e3, content=<a href='/topic/show?id=89df506ea9' target=_blank style='color:#2F92EE;'>#CONSORT规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5067, encryptionId=89df506ea9, topicName=CONSORT规范)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Thu Dec 13 06:54:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558468, encodeId=9b431558468da, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564477, encodeId=3c4e15644e782, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304803, encodeId=8b603048038d, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:40 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-12-13 ms6980045490879608

    #CONSORT规范#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2188589, encodeId=1912218858956, content=consort指南 求PDF, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231107/fc1e00c3671a452b933329d067a6c170/0c2cee4450c449e48382ba22e7e48ddb.jpg, createdBy=19109053436, createdName=阳～晨, createdTime=Wed Feb 21 23:18:07 CST 2024, time=2024-02-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2021210, encodeId=87ce2021210e3, content=<a href='/topic/show?id=89df506ea9' target=_blank style='color:#2F92EE;'>#CONSORT规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5067, encryptionId=89df506ea9, topicName=CONSORT规范)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Thu Dec 13 06:54:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558468, encodeId=9b431558468da, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564477, encodeId=3c4e15644e782, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304803, encodeId=8b603048038d, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:40 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-13 tomyang91

    #CONSORT#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2188589, encodeId=1912218858956, content=consort指南 求PDF, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231107/fc1e00c3671a452b933329d067a6c170/0c2cee4450c449e48382ba22e7e48ddb.jpg, createdBy=19109053436, createdName=阳～晨, createdTime=Wed Feb 21 23:18:07 CST 2024, time=2024-02-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2021210, encodeId=87ce2021210e3, content=<a href='/topic/show?id=89df506ea9' target=_blank style='color:#2F92EE;'>#CONSORT规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5067, encryptionId=89df506ea9, topicName=CONSORT规范)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Thu Dec 13 06:54:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558468, encodeId=9b431558468da, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564477, encodeId=3c4e15644e782, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304803, encodeId=8b603048038d, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:40 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-13 tomyang91

    #CONSORT#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2188589, encodeId=1912218858956, content=consort指南 求PDF, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231107/fc1e00c3671a452b933329d067a6c170/0c2cee4450c449e48382ba22e7e48ddb.jpg, createdBy=19109053436, createdName=阳～晨, createdTime=Wed Feb 21 23:18:07 CST 2024, time=2024-02-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2021210, encodeId=87ce2021210e3, content=<a href='/topic/show?id=89df506ea9' target=_blank style='color:#2F92EE;'>#CONSORT规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5067, encryptionId=89df506ea9, topicName=CONSORT规范)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Thu Dec 13 06:54:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558468, encodeId=9b431558468da, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564477, encodeId=3c4e15644e782, content=<a href='/topic/show?id=a988506424' target=_blank style='color:#2F92EE;'>#CONSORT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5064, encryptionId=a988506424, topicName=CONSORT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a14990568, createdName=tomyang91, createdTime=Fri Apr 13 05:54:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304803, encodeId=8b603048038d, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:40 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-11 龙胆草

    学习谢谢分享

    0

相关资讯

SCI写作之结果

SCI写作之结果图1.RCT研究患者招募流程图 图2.基线资料表图3.疗效表格图4.安全性表格图5.患者招募流程图RCT研究的结局有主要终点和次要终点之分，研究终点有几种形式，见下表

SCI写作之前言

SCI写作之前言以上就是对SCI写作前言部分的知识和技巧分享，并希望大家能够有所收获，下一期，我们将继续介绍SCI写作的方法学部分内容，敬请期待！

非随机对照试验报告规范——TREND规范简介

TREND规范简介以上就是非随机对照研究写作规范TREND Checklist的内容，需要注意的是，TREND规范只适用于采用非随机设计的关于干预效果评价的研究，并不适用于所有的非随机试验研究。希望大家通过本节的介绍，了解并严格按照TREND规范内容进行非随机对照研究报告的撰写。

SCI写作之题目与摘要

SCI写作之题目与摘要

SCI写作之讨论

SCI写作之讨论

SCI写作之方法

科研基金